Oxford boosts life science arm with $125m Boston acquisition

Oxford Properties Group has acquired a large biomanufacturing development project in Boston, USA, in a $125 million sale and leaseback transaction.

You have reached premium content

Our readers look to Real Asset Insight to stay informed about the issues that matter in the real asset markets. Log in, start a free trial or subscribe below.

45 Day Free Trial – Real Asset INSIGHT & IMPACT
Start your trial today
0.00
30 days full access

Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.

45 DAY TRIAL MEMBERSHIP

Be part of the leading real asset community!

Get your free trial now
Real Asset INSIGHT Premium
Taking you beyond the headlines
495.00
12 month Subscription

SUBSCRIBE NOW

Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.

Be part of the leading real asset community and subscribe now! 

Subscribe now
Already a member? Log in here
Author: